Caris Life Sciences, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +38.7% | -7.6% | -69.8% | +248.6% | +28.2% | -21.5% | +19.4% | +61.4% | +38.4% | +22.1% | +7.1% | +9.7% | +17.9% | +18.4% | +24.0% | -3.6% | -29.4% | -12.1% | +18.4% | +34.7% | +97.0% | |
| – | – | – | – | +244.0% | +20.7% | +78.8% | -29.2% | -10.6% | +777.1% | +38.8% | +16.2% | +58.7% | +26.7% | +14.2% | +22.0% | -1.1% | -49.1% | +62.5% | +21.5% | +7.7% | +16.9% | |
| – | +38.7% | -7.6% | -71.7% | +248.9% | +28.7% | -27.8% | +26.8% | +67.6% | +4.5% | +15.7% | +3.0% | -15.8% | +9.2% | +23.1% | +26.2% | -6.1% | -8.2% | -56.5% | +11.6% | +100.2% | +201.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +15.4% | -2.5% | -60.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +29.2% | +19.7% | +17.8% | +4.8% | -48.2% | +471.7% | -2.7% | +14.2% | +29.6% | |
| – | -1.6% | -14.3% | -85.6% | +287.7% | +62.6% | -0.8% | +3.1% | +60.8% | -37.5% | +25.5% | +19.8% | +9.9% | +23.7% | -11.1% | +1.9% | +8.3% | -35.8% | +778.1% | +3.3% | +6.6% | +13.3% | |
| – | +524.0% | +4.9% | -50.1% | +231.5% | +10.9% | -48.4% | +61.9% | +73.9% | +40.9% | +11.9% | -4.3% | -29.8% | -3.1% | +60.2% | +40.8% | -12.4% | +6.8% | -327.0% | – | – | – | |
| – | +3.6% | +1.9% | -52.4% | +180.1% | -10.2% | -53.9% | +22.4% | +205.8% | +78.4% | +25.0% | -2.2% | +2.3% | +18.6% | +24.1% | +47.7% | +1.0% | -22.2% | -56.7% | +18.5% | +58.3% | +13.6% | |
| – | – | +6.4% | -49.0% | +263.2% | -150.8% | – | +81.7% | +94.9% | +19.7% | -3.4% | -5.6% | -53.8% | -68.4% | +479.1% | +42.5% | -32.2% | -46.5% | -1,186.3% | – | – | – | |
| – | – | +3.7% | -51.1% | +255.9% | +4.0% | -66.1% | -9.3% | +211.8% | -11.4% | -28.1% | +1.9% | -40.9% | -9.6% | -486.6% | – | +45.2% | -57.1% | – | – | – | – | |
| – | – | +8.2% | -47.6% | +267.6% | -240.1% | – | +109.4% | +76.8% | +26.5% | +0.7% | -5.7% | -55.5% | -77.7% | +1,101.6% | +9.1% | -60.5% | -10.6% | -1,256.8% | – | – | – | |
| – | +102.2% | +1.2% | -61.7% | +244.8% | -77.7% | +254.8% | +46.4% | +89.1% | +34.7% | +15.5% | +3.5% | -0.1% | -12.2% | +40.3% | +26.8% | -12.4% | +2.5% | -196.6% | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.